The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.
Barata
João T
JT
Instituto de Medicina Molecular, Faculdade de Medicina, Unversidade de Lisboa, Lisboa, Portugal. joao_barata@fm.ul.pt
D000818:Animals; D047390:Casein Kinase II / Q000235:genetics / Q000378:metabolism*; D002470:Cell Survival / Q000502:physiology*; D006801:Humans; D007938:Leukemia / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology*; D009154:Mutation; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D051059:PTEN Phosphohydrolase / Q000235:genetics / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*
D019869:Phosphatidylinositol 3-Kinases; D047390:Casein Kinase II; D051057:Proto-Oncogene Proteins c-akt; D051059:PTEN Phosphohydrolase